 | • レポートコード：D0GIR-06865 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、避妊薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。避妊薬の種類別市場規模（経口避妊薬、注射剤、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Piramal Enterprises、Bayer、Pfizer、Mankind Pharma、Teva Pharmaceutical、Church & Dwight、Janssen、Allergan、Reckitt Benckiser ・地域別グローバル市場分析 2015年-2020年 ・避妊薬の北米市場（アメリカ、カナダ、メキシコ） ・避妊薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・避妊薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・避妊薬の南米市場（ブラジル、アルゼンチン） ・避妊薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口避妊薬、注射剤、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Contraceptive Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 12630 million by 2025, from USD 10930 million in 2019.
The Contraceptive Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Contraceptive Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Contraceptive Drugs market has been segmented into
Oral Contraceptives
Injectable
Others
By Application, Contraceptive Drugs has been segmented into:
Hospitals
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Contraceptive Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Contraceptive Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Contraceptive Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Contraceptive Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Contraceptive Drugs Market Share Analysis
Contraceptive Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Contraceptive Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Contraceptive Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Contraceptive Drugs are:
Merck
Piramal Enterprises
Bayer
Pfizer
Mankind Pharma
Teva Pharmaceutical
Church & Dwight
Janssen
Allergan
Reckitt Benckiser
Among other players domestic and global, Contraceptive Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Contraceptive Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Contraceptive Drugs, with price, sales, revenue and global market share of Contraceptive Drugs in 2018 and 2019.
Chapter 3, the Contraceptive Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Contraceptive Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Contraceptive Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Contraceptive Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Contraceptive Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Contraceptive Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral Contraceptives
1.2.3 Injectable
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Contraceptive Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Overview of Global Contraceptive Drugs Market
1.4.1 Global Contraceptive Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Piramal Enterprises
2.2.1 Piramal Enterprises Details
2.2.2 Piramal Enterprises Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Piramal Enterprises SWOT Analysis
2.2.4 Piramal Enterprises Product and Services
2.2.5 Piramal Enterprises Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mankind Pharma
2.5.1 Mankind Pharma Details
2.5.2 Mankind Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mankind Pharma SWOT Analysis
2.5.4 Mankind Pharma Product and Services
2.5.5 Mankind Pharma Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pharmaceutical SWOT Analysis
2.6.4 Teva Pharmaceutical Product and Services
2.6.5 Teva Pharmaceutical Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Church & Dwight
2.7.1 Church & Dwight Details
2.7.2 Church & Dwight Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Church & Dwight SWOT Analysis
2.7.4 Church & Dwight Product and Services
2.7.5 Church & Dwight Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Janssen
2.8.1 Janssen Details
2.8.2 Janssen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Janssen SWOT Analysis
2.8.4 Janssen Product and Services
2.8.5 Janssen Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Allergan
2.9.1 Allergan Details
2.9.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Allergan SWOT Analysis
2.9.4 Allergan Product and Services
2.9.5 Allergan Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Reckitt Benckiser
2.10.1 Reckitt Benckiser Details
2.10.2 Reckitt Benckiser Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Reckitt Benckiser SWOT Analysis
2.10.4 Reckitt Benckiser Product and Services
2.10.5 Reckitt Benckiser Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Contraceptive Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Contraceptive Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Contraceptive Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Contraceptive Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Contraceptive Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Contraceptive Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Contraceptive Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Contraceptive Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Contraceptive Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Contraceptive Drugs Sales and Growth Rate (2015-2020)
4.5 South America Contraceptive Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Contraceptive Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Contraceptive Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Contraceptive Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Contraceptive Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Contraceptive Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Contraceptive Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Contraceptive Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Contraceptive Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Contraceptive Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Contraceptive Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Contraceptive Drugs Sales and Growth Rate (2015-2020)
6.3 UK Contraceptive Drugs Sales and Growth Rate (2015-2020)
6.4 France Contraceptive Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Contraceptive Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Contraceptive Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Contraceptive Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Contraceptive Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Contraceptive Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Contraceptive Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Contraceptive Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Contraceptive Drugs Sales and Growth Rate (2015-2020)
7.5 India Contraceptive Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Contraceptive Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Contraceptive Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Contraceptive Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Contraceptive Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Contraceptive Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Contraceptive Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Contraceptive Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Contraceptive Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Contraceptive Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Contraceptive Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Contraceptive Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Contraceptive Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Contraceptive Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Contraceptive Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Contraceptive Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Contraceptive Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Contraceptive Drugs Price by Type (2015-2020)
11 Global Contraceptive Drugs Market Segment by Application
11.1 Global Contraceptive Drugs Sales Market Share by Application (2015-2020)
11.2 Global Contraceptive Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Contraceptive Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Contraceptive Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Contraceptive Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Contraceptive Drugs Market Forecast (2021-2025)
12.2.2 Europe Contraceptive Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Contraceptive Drugs Market Forecast (2021-2025)
12.2.4 South America Contraceptive Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Contraceptive Drugs Market Forecast (2021-2025)
12.3 Contraceptive Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Contraceptive Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Contraceptive Drugs Market Share Forecast by Type (2021-2025)
12.4 Contraceptive Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Contraceptive Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Contraceptive Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Contraceptive Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Contraceptive Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Contraceptive Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Contraceptive Drugs Major Business
Table 9. Merck Contraceptive Drugs Total Revenue (USD Million) (2018-2019)
Table 10. Merck SWOT Analysis
Table 11. Merck Contraceptive Drugs Product and Services
Table 12. Merck Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Piramal Enterprises Basic Information, Manufacturing Base and Competitors
Table 14. Piramal Enterprises Contraceptive Drugs Major Business
Table 15. Piramal Enterprises Contraceptive Drugs Total Revenue (USD Million) (2018-2019)
Table 16. Piramal Enterprises SWOT Analysis
Table 17. Piramal Enterprises Contraceptive Drugs Product and Services
Table 18. Piramal Enterprises Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Contraceptive Drugs Major Business
Table 21. Bayer Contraceptive Drugs Total Revenue (USD Million) (2018-2019)
Table 22. Bayer SWOT Analysis
Table 23. Bayer Contraceptive Drugs Product and Services
Table 24. Bayer Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Contraceptive Drugs Major Business
Table 27. Pfizer Contraceptive Drugs Total Revenue (USD Million) (2018-2019)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Contraceptive Drugs Product and Services
Table 30. Pfizer Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Mankind Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Mankind Pharma Contraceptive Drugs Major Business
Table 33. Mankind Pharma Contraceptive Drugs Total Revenue (USD Million) (2018-2019)
Table 34. Mankind Pharma SWOT Analysis
Table 35. Mankind Pharma Contraceptive Drugs Product and Services
Table 36. Mankind Pharma Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 38. Teva Pharmaceutical Contraceptive Drugs Major Business
Table 39. Teva Pharmaceutical Contraceptive Drugs Total Revenue (USD Million) (2018-2019)
Table 40. Teva Pharmaceutical SWOT Analysis
Table 41. Teva Pharmaceutical Contraceptive Drugs Product and Services
Table 42. Teva Pharmaceutical Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Church & Dwight Basic Information, Manufacturing Base and Competitors
Table 44. Church & Dwight Contraceptive Drugs Major Business
Table 45. Church & Dwight Contraceptive Drugs Total Revenue (USD Million) (2018-2019)
Table 46. Church & Dwight SWOT Analysis
Table 47. Church & Dwight Contraceptive Drugs Product and Services
Table 48. Church & Dwight Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Janssen Basic Information, Manufacturing Base and Competitors
Table 50. Janssen Contraceptive Drugs Major Business
Table 51. Janssen Contraceptive Drugs Total Revenue (USD Million) (2018-2019)
Table 52. Janssen SWOT Analysis
Table 53. Janssen Contraceptive Drugs Product and Services
Table 54. Janssen Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Allergan Basic Information, Manufacturing Base and Competitors
Table 56. Allergan Contraceptive Drugs Major Business
Table 57. Allergan Contraceptive Drugs Total Revenue (USD Million) (2018-2019)
Table 58. Allergan SWOT Analysis
Table 59. Allergan Contraceptive Drugs Product and Services
Table 60. Allergan Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Reckitt Benckiser Basic Information, Manufacturing Base and Competitors
Table 62. Reckitt Benckiser Contraceptive Drugs Major Business
Table 63. Reckitt Benckiser Contraceptive Drugs Total Revenue (USD Million) (2018-2019)
Table 64. Reckitt Benckiser SWOT Analysis
Table 65. Reckitt Benckiser Contraceptive Drugs Product and Services
Table 66. Reckitt Benckiser Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Contraceptive Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Contraceptive Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Contraceptive Drugs Sales by Regions (2015-2020) (K Units)
Table 70. Global Contraceptive Drugs Sales Market Share by Regions (2015-2020)
Table 71. Global Contraceptive Drugs Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Contraceptive Drugs Sales by Countries (2015-2020) (K Units)
Table 73. North America Contraceptive Drugs Sales Market Share by Countries (2015-2020)
Table 74. North America Contraceptive Drugs Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Contraceptive Drugs Revenue Market Share by Countries (2015-2020)
Table 76. Europe Contraceptive Drugs Sales by Countries (2015-2020) (K Units)
Table 77. Europe Contraceptive Drugs Sales Market Share by Countries (2015-2020)
Table 78. Europe Contraceptive Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Contraceptive Drugs Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Contraceptive Drugs Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Contraceptive Drugs Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Contraceptive Drugs Sales by Countries (2015-2020) (K Units)
Table 83. South America Contraceptive Drugs Sales Market Share by Countries (2015-2020)
Table 84. South America Contraceptive Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Contraceptive Drugs Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Contraceptive Drugs Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Contraceptive Drugs Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Contraceptive Drugs Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Contraceptive Drugs Revenue Market Share by Countries (2015-2020)
Table 90. Global Contraceptive Drugs Sales by Type (2015-2020) (K Units)
Table 91. Global Contraceptive Drugs Sales Share by Type (2015-2020)
Table 92. Global Contraceptive Drugs Revenue by Type (2015-2020) (USD Million)
Table 93. Global Contraceptive Drugs Revenue Share by Type (2015-2020)
Table 94. Global Contraceptive Drugs Sales by Application (2015-2020) (K Units)
Table 95. Global Contraceptive Drugs Sales Share by Application (2015-2020)
Table 96. Global Contraceptive Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Contraceptive Drugs Market Share Forecast by Regions (2021-2025)
Table 98. Global Contraceptive Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Contraceptive Drugs Market Share Forecast by Type (2021-2025)
Table 100. Global Contraceptive Drugs Sales Forecast by Application (2021-2025)
Table 101. Global Contraceptive Drugs Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Contraceptive Drugs Picture
Figure 2. Global Sales Market Share of Contraceptive Drugs by Type in 2019
Figure 3. Oral Contraceptives Picture
Figure 4. Injectable Picture
Figure 5. Others Picture
Figure 6. Contraceptive Drugs Sales Market Share by Application in 2018
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Others Picture
Figure 10. Global Contraceptive Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Contraceptive Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Contraceptive Drugs Sales Market Share by Manufacturer in 2019
Figure 31. Global Contraceptive Drugs Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Contraceptive Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Contraceptive Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Contraceptive Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Contraceptive Drugs Revenue Market Share by Regions (2015-2020)
Figure 38. Global Contraceptive Drugs Revenue Market Share by Regions in 2018
Figure 39. North America Contraceptive Drugs Sales and Growth Rate (2015-2020)
Figure 40. Europe Contraceptive Drugs Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Contraceptive Drugs Sales and Growth Rate (2015-2020)
Figure 42. South America Contraceptive Drugs Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Contraceptive Drugs Sales and Growth Rate (2015-2020)
Figure 44. North America Contraceptive Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Contraceptive Drugs Sales Market Share by Countries (2015-2020)
Figure 46. North America Contraceptive Drugs Sales Market Share by Countries in 2018
Figure 47. North America Contraceptive Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Contraceptive Drugs Revenue Market Share by Countries in 2018
Figure 49. United States Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Contraceptive Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Contraceptive Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Contraceptive Drugs Revenue Market Share by Countries in 2019
Figure 55. Germany Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Contraceptive Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Contraceptive Drugs Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Contraceptive Drugs Revenue Market Share by Regions 2019
Figure 63. China Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Contraceptive Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Contraceptive Drugs Sales Market Share by Countries in 2019
Figure 70. South America Contraceptive Drugs Revenue Market Share by Countries in 2019
Figure 71. Brazil Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Contraceptive Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Contraceptive Drugs Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Contraceptive Drugs Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Contraceptive Drugs Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Contraceptive Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Contraceptive Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Contraceptive Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Contraceptive Drugs Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Contraceptive Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Contraceptive Drugs Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Contraceptive Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Contraceptive Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
避妊薬・避妊具の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Contraceptive Drugs and Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to 2025 and will expected to reach USD 7932.9 million by 2025, from USD 6720.8 million in 2019. The Cont…- 糖尿病用注射薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Injectable Drugs For Diabetes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 2型糖尿病用注射薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Injectable Drugs For Type-2 Diabete market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 口腔粘膜炎治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drugs for Oral Mucositis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drugs for Oral Mucos…
- 鎮痙薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Antispasmodics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …